This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Albemarle (ALB) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Albemarle (ALB) faces some volume headwinds in its lithium unit in the first quarter.
What's in Store for Kirkland Lake Gold (KL) in Q1 Earnings?
by Zacks Equity Research
Kirkland Lake Gold's (KL) Q1 results are likely to gain from higher production at Macassa and Fosterville.
What's in Store for Israel Chemicals (ICL) in Q1 Earnings?
by Zacks Equity Research
Our proven model does not show that Israel Chemicals (ICL) is likely to beat estimates this quarter.
FMC Corp (FMC) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not show that FMC Corp (FMC) is likely to beat estimates in Q1.
What's in Store for International Flavors' (IFF) Q1 Earnings?
by Zacks Equity Research
While International Flavors & Fragrances (IFF) is likely to benefit from favorable markets and new wins in the first quarter of fiscal 2019, raw material cost inflation might be a deterrent.
Mosaic (MOS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic (MOS) will likely witness some pressure on volumes and pricing in Q1.
What's in Store for Scotts Miracle-Gro (SMG) in Q2 Earnings?
by Zacks Equity Research
Scotts Miracle-Gro's (SMG) fiscal Q2 results to benefit from growth in the Hawthorne segment.
CF Industries (CF) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CF Industries (CF) to benefit from higher demand of nitrogen fertilizers in Q1.
The Zacks Analyst Blog Highlights: Jabil, Fabrinet, Intrepid Potash, EnerSys and Sealed Air
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Jabil, Fabrinet, Intrepid Potash, EnerSys and Sealed Air
Optimism Rises Ahead of US-China Trade Talks: 6 Gainers
by Swarup Gupta
Important figures from the Trump administration and members of industry believe a trade deal with China in the near term is likely.
6 Stocks Set to Gain as U.S.-China Trade Tensions Ease
by Swarup Gupta
Media reports indicate that a resolution to the long-running dispute may be in sight.
Options Traders Expect Huge Moves in Intrepid Potash (IPI) Stock
by Zacks Equity Research
Intrepid Potash (IPI) needs investors to pay close attention to the stock based on moves in the options market lately.
Fertilizers Industry Outlook: Near-Term Prospects Cloudy
by Zacks Equity Research
While the fertilizers makers are witnessing an improving nutrient demand and pricing environment, weak agricultural commodity prices and escalating trade tensions may weigh on the industry.
Moving Average Crossover Alert: Intrepid Potash (IPI)
by Zacks Equity Research
Intrepid Potash, Inc. (IPI) could be a stock to avoid from a technical perspective
Options Traders Expect Huge Moves in Intrepid Potash (IPI) Stock
by Zacks Equity Research
Investors need to pay close attention to Intrepid Potash (IPI) stock based on the movements in the options market lately.
Intrepid Potash (IPI): Moving Average Crossover Alert
by Zacks Equity Research
Intrepid Potash, Inc. (IPI) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
Intrepid Potash (IPI) Catches Eye: Stock Jumps 8.5%
by Zacks Equity Research
Intrepid Potash (IPI) shares rose nearly 9% in the last trading session, amid huge volumes.
Deere, CenturyLink, Mosaic, Sociedad Quimica y Minera de Chile S.A. and Intrepid Potash highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Deere, CenturyLink, Mosaic, Sociedad Quimica y Minera de Chile S.A. and Intrepid Potash highlighted as Zacks Bull and Bear of the Day
Sociedad Quimica y Minera de Chile (SQM) Looks Good: Stock Adds 5.1% in Session
by Zacks Equity Research
Sociedad Quimica y Minera de Chile (SQM) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
Zacks.com featured highlights Summer Infant, Intra-Cellular Therapies, PDL BioPharma, Cogentix Medical and Intrepid Potash
by Zacks Equity Research
Zacks.com featured highlights Summer Infant, Intra-Cellular Therapies, PDL BioPharma, Cogentix Medical and Intrepid Potash
Why Intrepid Potash (IPI) Could Be Positioned for a Surge
by Zacks Equity Research
Intrepid Potash (IPI) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.
Is the Options Market Predicting a Spike in Intrepid Potash (IPI) Stock?
by Zacks Equity Research
Investors in Intrepid Potash, Inc. (IPI) need to pay close attention to the stock based on moves in the options market lately.
5 Bargain Breakout Stocks Offering Stunning Returns
by Swarup Gupta
The key to this kind of stock selection is to identify players that are trading within a narrow band.
Intrepid Potash (IPI) Looks Good: Stock Adds 7.3% in Session
by Zacks Equity Research
Intrepid Potash, Inc. (IPI) shares rose over 7% in the last trading session.
Century Aluminum (CENX) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Century Aluminum (CENX) is scheduled to report fourth-quarter 2016 results after the closing bell on Feb 23.